Hospitals & Health Systems

With healthcare drowning in a $1 trillion administrative burden, CAQH's rebrand to DataSpring is more than a name change—it's a high-stakes bet.

With expanded coverage for 52 million Americans, Tonix Pharmaceuticals' TONMYA® is not just a drug launch; it's a market disruption for chronic pain.

As GLP-1 drugs dominate, a UK biotech reveals a new drug that targets mitochondria, promising superior fat loss while preserving precious muscle mass.

A new partnership between PAM Health and Marshall Health Network isn't just building a hospital; it's creating a new healthcare and economic hub for South Point.

Ottawa's first national eye care strategy isn't just about health. It's a calculated investment in economic resilience and systemic stability for an aging nation.

Zealand Pharma's petrelintide shows double-digit weight loss with remarkably few side effects, positioning it to challenge GLP-1 giants in the $100B market.

DBV Technologies heads to a key investor conference with its VIASKIN patch for peanut allergies. Can its science and strategy convince Wall Street?

With Brian Ewart's appointment as General Counsel, the nonprofit signals a new era of disciplined growth, leveraging top legal talent to navigate complex federal contracts.

The S&P/TSX Composite's latest rebalance is more than a market footnote. It's a story of rising commodity players and struggling consumer-facing firms.

Florida Southern College secures a rare 10-year nursing accreditation, signaling a critical boost for a state grappling with a persistent nursing shortage.

Amid a regional healthcare crisis, 475 nurses at BMC South plan to picket, citing unsafe staffing and a 'bullying' contract offer from management.

A new class of doctor is bridging the gap between lab and patient. Meet the physician-scientists tackling deadly diseases with revolutionary new approaches.

A new acquisition seems routine, but it's part of Principle Health's aggressive strategy to build a diagnostic empire for long-term care. Here's why.

NaphCare defends its Alabama prison healthcare contract, touting awards and stability. But can its playbook build lasting value in a deeply troubled system?

With millions set to lose Medicaid under new federal rules, Azara Healthcare’s acquisition of Advocatia creates a new tech arsenal for at-risk providers.

As Liberty Hill's population skyrockets, the arrival of a freestanding ER ends residents' long drives for urgent care, a milestone for the booming suburb.

A pharma revolution is brewing for Generalized Anxiety Disorder. As prevalence soars, novel therapies targeting new neural pathways promise to upend the market.

May's headline job growth masks a troubling reality. New data from Revelio Labs reveals a deepening divide between sectors and a drop in new-hire pay.

A new study reveals treating advanced gum disease has up to 10x the environmental impact of prevention, reframing sustainability from recycling to daily habits.

VSP Vision Care's 2026 top ranking signals a growing focus on vision insurance for both financial savings and proactive physical health management.